- Biodesix to Participate in Two Investor Conferences in June
- Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
- Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
- Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
- Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
- Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
- Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
- Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
- Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
More ▼
Key statistics
On Tuesday, Biodesix Inc (BDSX:NMQ) closed at 1.45, 40.78% above the 52 week low of 1.03 set on Jul 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.45 |
---|---|
High | 1.46 |
Low | 1.39 |
Bid | 1.35 |
Offer | 2.32 |
Previous close | 1.45 |
Average volume | 106.38k |
---|---|
Shares outstanding | 114.69m |
Free float | 44.52m |
P/E (TTM) | -- |
Market cap | 166.29m USD |
EPS (TTM) | -0.5465 USD |
Data delayed at least 15 minutes, as of May 28 2024 21:00 BST.
More ▼